The Pursuit of Clinically Relevant Measures of Platelet Function After Antiplatelet Drug Therapy

被引:2
|
作者
Cairns, John A. [1 ]
Eikelboom, John [2 ]
机构
[1] Univ British Columbia, Dept Med, GLD Hlth Care Ctr, Vancouver, BC V5Z 1M9, Canada
[2] McMaster Univ, Dept Med, Hamilton, ON, Canada
关键词
clopidogrel; antiplatelet drugs; platelet function tests; clopidogrel resistance;
D O I
10.1016/j.jacc.2008.08.053
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1978 / 1980
页数:3
相关论文
共 50 条
  • [41] Dual antiplatelet therapy tailored on platelet function test after coronary stent implantation: a real-world experience
    Cecchi, Emanuele
    Marcucci, Rossella
    Chiostri, Marco
    Mecarocci, Valerio
    Spini, Valentina
    Innocenti, Lisa
    Calabretta, Raffaella
    Cordisco, Antonella
    Romano, Salvatore Mario
    Abbate, Rosanna
    Gensini, Gian Franco
    Giglioli, Cristina
    INTERNAL AND EMERGENCY MEDICINE, 2015, 10 (07) : 805 - 814
  • [42] Dual antiplatelet therapy tailored on platelet function test after coronary stent implantation: a real-world experience
    Emanuele Cecchi
    Rossella Marcucci
    Marco Chiostri
    Valerio Mecarocci
    Valentina Spini
    Lisa Innocenti
    Raffaella Calabretta
    Antonella Cordisco
    Salvatore Mario Romano
    Rosanna Abbate
    Gian Franco Gensini
    Cristina Giglioli
    Internal and Emergency Medicine, 2015, 10 : 805 - 814
  • [43] ALTERATIONS IN PLATELET-FUNCTION MONITORED DURING AND AFTER CORONARY REVASCULARIZATION - IMPLICATIONS FOR THE TIMING, EFFICACY AND SAFETY OF ANTIPLATELET THERAPY
    RATNATUNGA, CP
    REES, GM
    KOVACS, IB
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1142 - 1142
  • [44] Is the measurement error of serum creatinine clinically relevant for drug dosage adjustment to kidney function?
    Schneider, V
    Henschel, V
    Mansmann, U
    Tadjalli-Mehr, K
    Haefeli, WE
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (07) : S84 - S84
  • [45] Enhanced platelet inhibition by adjunctive cilostazol to dual antiplatelet therapy after drug-eluting stent implantation for complex lesions
    Jeong, Young-Hoon
    Park, Yongwhi
    Kim, In-Suk
    Yun, Seong-Eun
    Kang, Min-Kyung
    Hwang, Seok-Jae
    Kwak, Choong Hwan
    Hwang, Jin-Yong
    THROMBOSIS AND HAEMOSTASIS, 2010, 104 (06) : 1286 - 1289
  • [46] Physicians' Response To Platelet Function Testing After Percutaneous Coronary Therapy: Does High On-Treatment Platelet Reactivity Testing Impact Antiplatelet Strategy?
    Sardi, Gabriel
    Loh, Joshua
    Kitabata, Hironori
    Torguson, Rebecca
    Kent, Kenneth
    Satler, Lowell
    Suddath, William
    Pichard, Augusto
    Waksman, Ron
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B218 - B218
  • [47] Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant?
    Hamdi, Amir Imran Faisal
    How, Soon Hin
    Islam, Mohammad Kaisarul
    Lim, Jonathan Chee Woei
    Stanslas, Johnson
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (12) : 1309 - 1323
  • [48] Duration of Dual Antiplatelet Therapy after Drug-Eluting Stents
    Tomoda, Haruo
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (14): : 1372 - 1373
  • [49] Can antiplatelet therapy after drug eluting stent become a problem?
    Romano, Michele
    CLINICAL MANAGEMENT ISSUES, 2009, 3 (01) : 27 - 32
  • [50] Hemorrhage after thrombolytic therapy for stroke - The clinically relevant number needed to harm
    Saver, Jeffrey L.
    STROKE, 2007, 38 (08) : 2279 - 2283